Schrödinger selects Sapio Sciences to enhance in silico drug discovery from plasmid to structure

Al­giax Phar­ma­ceu­ti­cals’ non-opi­oid can­di­date has achieved “clin­i­cal­ly mean­ing­ful” pain re­duc­tion in a mid-stage tri­al of peo­ple with pe­riph­er­al post-sur­gi­cal neu­ro­path­ic pain, mark­ing an­oth­er suc­cess in

DENVER — Genetic testing and algorithms revealed that over 1% of more than 96,000 blastocyst-stage embryos had ploidy abnormalities, or atypical numbers of chromosomes. In